Free Trial

Wells Fargo & Company MN Has $58.56 Million Holdings in Relx Plc (NYSE:RELX)

Relx logo with Computer and Technology background
Remove Ads

Wells Fargo & Company MN cut its position in shares of Relx Plc (NYSE:RELX - Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,289,270 shares of the technology company's stock after selling 22,046 shares during the quarter. Wells Fargo & Company MN owned about 0.07% of Relx worth $58,559,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of RELX. CENTRAL TRUST Co lifted its stake in shares of Relx by 1,290.2% during the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc acquired a new stake in Relx in the fourth quarter valued at approximately $31,000. Sierra Ocean LLC acquired a new position in shares of Relx during the fourth quarter worth $43,000. Brown Brothers Harriman & Co. boosted its stake in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock valued at $44,000 after purchasing an additional 662 shares during the period. Finally, Private Trust Co. NA increased its stake in Relx by 19.2% during the 4th quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock worth $56,000 after buying an additional 199 shares during the period. 15.02% of the stock is owned by institutional investors and hedge funds.

Relx Price Performance

Shares of NYSE RELX traded up $0.75 during mid-day trading on Monday, reaching $49.87. 183,905 shares of the company traded hands, compared to its average volume of 721,403. The firm has a market cap of $92.30 billion, a PE ratio of 26.81, a price-to-earnings-growth ratio of 2.73 and a beta of 0.84. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The stock has a fifty day simple moving average of $49.29 and a 200-day simple moving average of $47.87.

Remove Ads

Relx Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Friday, May 9th will be paid a dividend of $0.5586 per share. The ex-dividend date of this dividend is Friday, May 9th. This is a positive change from Relx's previous semi-annual dividend of $0.23. This represents a yield of 1.6%. Relx's dividend payout ratio is currently 59.68%.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. Redburn Atlantic started coverage on shares of Relx in a report on Wednesday, January 8th. They issued a "buy" rating on the stock. The Goldman Sachs Group initiated coverage on shares of Relx in a report on Wednesday, March 26th. They set a "buy" rating for the company. Finally, StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Buy".

Get Our Latest Stock Analysis on RELX

Relx Profile

(Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Further Reading

Institutional Ownership by Quarter for Relx (NYSE:RELX)

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads